[1]葛家艳,尚靖智,任小花.寒喘祖帕颗粒配合乙酰半胱氨酸对COPD患者肺功能、TGF-β及MMP-9水平的影响[J].西部中医药,2021,34(04):113-116.[doi:10.12174/j.issn.2096-9600.2021.04.28]
 GE Jiayan,SHANG Jingzhi,REN Xiaohua.Effects of Hanchuan Zupa Granules and Acetylcysteine on Pulmonary Function, the Levels of TGF-β and MMP-9 in COPD Patients[J].Western Journal of Traditional Chinese Medicine,2021,34(04):113-116.[doi:10.12174/j.issn.2096-9600.2021.04.28]
点击复制

寒喘祖帕颗粒配合乙酰半胱氨酸对COPD患者肺功能、TGF-β及MMP-9水平的影响
分享到:

《西部中医药》[ISSN:2096-9600/CN:62-1204/R]

卷:
34
期数:
2021年04期
页码:
113-116
栏目:
衷中参西
出版日期:
2021-04-15

文章信息/Info

Title:
Effects of Hanchuan Zupa Granules and Acetylcysteine on Pulmonary Function, the Levels of TGF-β and MMP-9 in COPD Patients
作者:
葛家艳, 尚靖智, 任小花
庆阳市人民医院,甘肃 庆阳 745000
Author(s):
GE Jiayan, SHANG Jingzhi, REN Xiaohua
Qingyang City People′s Hospital, Qingyang 745000, China
关键词:
慢性阻塞性肺疾病寒喘祖帕颗粒乙酰半胱氨酸肺功能转化生长因子基质金属蛋白酶9
Keywords:
COPDgranulesacetylcysteinepulmonary functionTGF-MMP-9
分类号:
R563
DOI:
10.12174/j.issn.2096-9600.2021.04.28
摘要:
目的探讨寒喘祖帕颗粒配合乙酰半胱氨酸对慢性阻塞性肺疾病(chronic obstructive pulmonary disease,COPD)患者肺功能、转化生长因子β(transforming growth factor-β,TGF-β)及基质金属蛋白酶9(matrix metalloprotein-9,MMP-9)水平的影响。 方法选取206例COPD患者,将受试者按入院顺序分为两组,每组103例。对照组接受乙酰半胱氨酸治疗,观察组在此基础上给予寒喘祖帕颗粒治疗,比较两组临床疗效、治疗前后各组肺功能指标及血清TGF-β、MMP-9水平变化情况和不良反应发生情况。 结果总有效率观察组为94.17%(97/103),对照组为77.67%(80/103),两组比较差异有统计学差异(P<0.05);治疗后两组一秒用力呼气容积(forced expiratory volume in one second,FEV1)、用力肺活量(forced vital capacity,FVC)呼气峰值流速(peak expiratory flow,PEF)、最大呼气中期流量(maximal mid-expiratory flow,MMEF)及FEV1/FVC较治疗前均明显提高(P<0.05),且观察组显著高于对照组(P<0.05);治疗后两组TGF-β及MMP-9水平较治疗前均明显降低,且观察组低于对照组(P<0.05);两组不良反应发生率比较,差异无统计学意义(P>0.05)。 结论寒喘祖帕颗粒配合乙酰半胱氨酸可有效改善COPD患者肺功能、降低TGF-β及MMP-9水平,且安全性高。
Abstract:
ObjectiveTo explore the effects of Hanchuan Zupa granules and acetylcysteine on pulmonary function, the levels of TGF-β and MMP-9 in COPD patients. MethodsAll 206 patients hospitalized were chosen and allocated to two groups, 103 patients of the control group were treated by acetylcysteine, and 103 patients of the observation group took Hanchuan Zupa granules orally, to compare clinical effects, the indexes of pulmonary functions in different groups before and after treating, the levels of TGF-β and MMP-9 and the incidence of adverse reaction between both groups. ResultsTotal effective rate of the observation group was 94.17%(97/103), higher than 77.67%(80/103) of the control group, and the difference showed statistical meaning between both groups (P<0.05); after the treatment, FEV1, FVC, PEF, MMEF and FEV1/FVC of the two groups increased apparently than before treating (P<0.05), and the observation group was notably higher than the control group, and the difference showed statistical meaning (P<0.05); after the treatment, the levels of TGF-β and MMP-9 in both groups were lower compared with these before treating, and the observation group was lower than the control group (P<0.05); the difference had no statistical meaning in the incidence of adverse reaction between both groups (P>0.05). ConclusionHanchuan Zupa granules and acetylcysteine could improve pulmonary function of the patients effectively, reduce the levels of TGF-β and MMP-9 with high safety.

相似文献/References:

[1]王萍.慢性阻塞性肺病患者实施临床护理路径的疗效分析[J].西部中医药,2014,27(11):140.
[2]王 燕,孙凤英,倪 军.慢性阻塞性肺疾病患者非药物治疗依从性与生活质量相关性的研究[J].西部中医药,2015,28(03):89.
[3]郭晓燕,尹广超,陆城华,等.川芎平喘合剂对COPD患者血管内皮功能的调节作用[J].西部中医药,2015,28(05):1.
[4]王振伟,杨佩兰,沈丽,等.百部养肺煎膏治疗COPD稳定期患者的临床研究[J].西部中医药,2015,28(05):56.
[5]赵宇冰,林丽明.老年慢性阻塞性肺疾病患者缓解期的社区康复治疗[J].西部中医药,2012,25(08):59.
 ZHAO Yu-bing,LIN Li-ming.Community Rehabilitation Therapy for Senile Patients with COPD at Remission Stage[J].Western Journal of Traditional Chinese Medicine,2012,25(04):59.
[6]张旭辉,杨虹.咳喘宁胶囊治疗稳定期慢性阻塞性肺疾病的疗效评价[J].西部中医药,2016,29(03):1.
 ZHANG Xuhui,YANG Hong.Evaluation of Clinical Effects of KeChuanNing Capsules in Treating Chronic Obstructive Pulmonary Disease at Stable Stage[J].Western Journal of Traditional Chinese Medicine,2016,29(04):1.
[7]晏燕,孙建勤,姜冰玉,等.中西医结合治疗老年慢性阻塞性肺疾病急性加重期的临床疗效[J].西部中医药,2016,29(07):96.
 YAN Yan,SUN Jianqin,JIANG Bingyu,et al.Clinical Effects of Integrative Medicine in Treating Chronic Obstructive Pulmonary Disease of Senile Patients at Acute Exacerbation[J].Western Journal of Traditional Chinese Medicine,2016,29(04):96.
[8]施巍,苟小军,王道才,等.刺络放血法治疗慢性阻塞性肺疾病急性加重期48例[J].西部中医药,2017,30(02):96.
 SHI Wei,GOU Xiaojun,WANG Daocai,et al.Blood-letting Therapy in Treating 48 Cases of Chronic Obstructive Pulmonary Disease at Acute Exacerbation Stage[J].Western Journal of Traditional Chinese Medicine,2017,30(04):96.
[9]郭晓燕,腾飞,张惠勇.川芎平喘合剂治疗慢性阻塞性肺疾病的随机对照研究[J].西部中医药,2018,31(01):1.
 GUO Xiaoyan,TENG Fei,ZHANG Huiyong.A Randomized, Controlled Study of ChuanXiong PingChuan Mixture in Treating Chronic Obstructive Pulmonary Disease[J].Western Journal of Traditional Chinese Medicine,2018,31(04):1.
[10]史素丽,尚秀娟△,曹凤英.老年慢性阻塞性肺疾病患者主观幸福度及影响因素分析[J].西部中医药,2016,29(01):93.
 SHI Suli,SHANG Xiujuan,CAO Fengying.Analysis of Influencing Factors and Subjective Happiness Index of Senile Patients with Chronic Obstructive Pulmonary Disease[J].Western Journal of Traditional Chinese Medicine,2016,29(04):93.

备注/Memo

备注/Memo:
葛家艳(1969—),女,副主任医师。研究方向:呼吸系统疾病的临床诊治。甘肃省科技厅青年科技基金(1506RJYM325)。
更新日期/Last Update: 2021-04-15